Jenny Stritzelberger , Katrin Walther , David Olmes , Stephanie Gollwitzer , Tamara M. Welte , Johannes D. Lang , Caroline Reindl , Stefan Schwab , Peter Kriwy , Hajo M. Hamer
{"title":"Factors influencing neurologists' prescribing of antiseizure medication: The role of physician biography and patient characteristics","authors":"Jenny Stritzelberger , Katrin Walther , David Olmes , Stephanie Gollwitzer , Tamara M. Welte , Johannes D. Lang , Caroline Reindl , Stefan Schwab , Peter Kriwy , Hajo M. Hamer","doi":"10.1016/j.seizure.2025.04.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Although committed to equal treatment, physicians may be influenced by various non-medical factors when deciding how to treat patients and allocate treatment costs. This study examines how biographical factors and patient characteristics influence physicians’ decisions in the context of antiseizure medication (ASM) prescriptions.</div></div><div><h3>Methods</h3><div>We re-analysed a cohort from a previous factorial study focusing on physicians’ characteristics. Vignettes showed a fictitious person with epilepsy (PWE) receiving a fictitious ASM. The characteristics of the PWE, the ASM and the epilepsy varied. We asked neurologists to rate the likelihood that they would prescribe the drug to the patient, and to complete a survey on personal characteristics (including age, sex, living situation, professional experience and contact with PWE).</div></div><div><h3>Results</h3><div>46 neurologists (age 37.1 ± 9.6 years, 65.2 % female) completed the questionnaire. Neurologists who rated themselves as being in the best possible health state or who had private contact with PWE were more likely to prescribe ASM.</div></div><div><h3>Conclusion</h3><div>Neurologists’ biographies and experiences influenced their decisions about the likelihood of prescribing ASM therapy.</div></div>","PeriodicalId":49552,"journal":{"name":"Seizure-European Journal of Epilepsy","volume":"129 ","pages":"Pages 55-58"},"PeriodicalIF":2.7000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seizure-European Journal of Epilepsy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1059131125000949","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Although committed to equal treatment, physicians may be influenced by various non-medical factors when deciding how to treat patients and allocate treatment costs. This study examines how biographical factors and patient characteristics influence physicians’ decisions in the context of antiseizure medication (ASM) prescriptions.
Methods
We re-analysed a cohort from a previous factorial study focusing on physicians’ characteristics. Vignettes showed a fictitious person with epilepsy (PWE) receiving a fictitious ASM. The characteristics of the PWE, the ASM and the epilepsy varied. We asked neurologists to rate the likelihood that they would prescribe the drug to the patient, and to complete a survey on personal characteristics (including age, sex, living situation, professional experience and contact with PWE).
Results
46 neurologists (age 37.1 ± 9.6 years, 65.2 % female) completed the questionnaire. Neurologists who rated themselves as being in the best possible health state or who had private contact with PWE were more likely to prescribe ASM.
Conclusion
Neurologists’ biographies and experiences influenced their decisions about the likelihood of prescribing ASM therapy.
期刊介绍:
Seizure - European Journal of Epilepsy is an international journal owned by Epilepsy Action (the largest member led epilepsy organisation in the UK). It provides a forum for papers on all topics related to epilepsy and seizure disorders.